By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Rare Disease and Brands128.24M54.01%
Generics and Other109.22M45.99%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States852.44M96.50%
International30.92M3.50%